PROCESS FOR THE PREPARATION OF PROLINE DERIVATIVES
    8.
    发明申请
    PROCESS FOR THE PREPARATION OF PROLINE DERIVATIVES 有权
    制备衍生物的方法

    公开(公告)号:US20130123512A1

    公开(公告)日:2013-05-16

    申请号:US13671586

    申请日:2012-11-08

    IPC分类号: C07D207/09

    CPC分类号: C07D207/09 C07D207/16

    摘要: The present invention relates in part to a process for the preparation of a proline derivative of formula I wherein, R1 is C1-7-alkyl or wherein R4 is selected from the group consisting of C1-7-alkyl, halogen-C1-7-alkyl and phenyl optionally substituted by halogen; R2 is halogen or halogen-C1-7-alkyl; and R3 is selected from the group consisting of hydrogen, halogen, halogen-C1-7-alkyl, C1-7-alkoxy, halogen-C1-7-alkoxy and a 5- or 6-membered heterocyclic ring containing one or two nitrogen atoms, said ring being optionally substituted by C1-7-alkyl or halogen. The proline derivatives of the formula I are preferential inhibitors of the cysteine protease Cathepsin S and are therefore useful to treat metabolic diseases like diabetes, atherosclerosis, abdominal aortic aneurysm, peripheral arterial disease and diabetic nephropathy.

    摘要翻译: 本发明部分涉及制备式I的脯氨酸衍生物的方法,其中R 1是C 1-7 - 烷基或其中R 4选自C 1-7 - 烷基,卤素-C 1-7 - 烷基和任选被卤素取代的苯基; R2是卤素或卤素-C1-7-烷基; 并且R 3选自氢,卤素,卤素-C 1-7 - 烷基,C 1-7 - 烷氧基,卤素-C 1-7 - 烷氧基和含有一个或两个氮原子的5-或6-元杂环 所述环任选被C 1-7 - 烷基或卤素取代。 式I的脯氨酸衍生物是半胱氨酸蛋白酶组织蛋白酶S的优先抑制剂,因此可用于治疗糖尿病,动脉粥样硬化,腹主动脉瘤,外周动脉疾病和糖尿病肾病等代谢疾病。